David Beckham-Backed Prenetics Doubles Down: $20M Bitcoin Bet Signals Healthcare’s Crypto Future
When traditional finance hesitates, healthcare leaps—Prenetics, the genomics disruptor backed by David Beckham, just dropped $20 million on Bitcoin. Here's why it matters.
The playbook: institutional adoption gets a celebrity boost
No vague "digital transformation" buzzwords here. This is cold, hard capital allocation—a healthcare org buying the dip while Wall Street still debates ETFs. The move mirrors MicroStrategy's playbook, but with Beckham's star power amplifying the signal.
Betting on scarcity in an inflationary world
With central banks printing fiat like confetti, Prenetics' treasury strategy now includes a hard-capped digital asset. Smart hedging—or reckless speculation? Either way, their balance sheet just got more interesting than most healthcare providers' NFT experiments.
The closer: a jab at the suits
While traditional CFOs still rebalance bond portfolios by candlelight, the Beckham-backed crew is stacking sats. Maybe those MBA programs should add a "meme stocks vs. sound money" module.

Prenetics Outlines Bold Vision With Bitcoin At Its Core
Prenetics isn’t simply parking idle cash in crypto. It plans to allocate the majority of its balance sheet to Bitcoin, with board approval already in place.
According to CEO Danny Yeung, the company sees a future where genomics, longevity science and digital assets converge. “To execute this vision at scale, we need substantial Bitcoin holdings,” he said.
The company has also brought in heavyweight crypto experience. Andy Cheung, former COO of exchange OKEx, is joining its board to provide direct oversight as Prenetics integrates digital assets into its operations. Cheung’s appointment strengthens the firm’s ability to navigate what remains a complex and volatile market.
Prenetics Follows MicroStrategy’s Playbook, But Adds A Healthcare Twist
Beyond buying and holding, Prenetics will actively manage its Bitcoin. The firm outlined plans for alpha-generating strategies that include lending, yield optimization and structured financial products.
In parallel, it will begin accepting cryptocurrency payments across its direct-to-consumer health platforms, building what it calls a full-stack Bitcoin ecosystem.
Prenetics raised its 2025 revenue forecast to as much as $100m and expects to turn profitable by the fourth quarter of next year. The Bitcoin strategy, the company says, reflects confidence in its business trajectory and its ability to manage risk.
Its move comes as dozens of public companies add Bitcoin to their treasuries. Sixty-one firms not traditionally involved in crypto have adopted similar strategies, according to Standard Chartered. Many are attempting to follow in the footsteps of MicroStrategy, which began its Bitcoin accumulation in 2020 and has since seen its stock rise over 3,000%.